脑外伤后哌甲酯使用实践指南:美国康复医学大会报告
该临床实践指南由美国康复医学大会多学科专家组制定,基于 accompanying 系统综述证据,针对创伤性脑损伤(TBI)亚急性期或慢性期成人的认知与非认知神经精神症状,给出哌甲酯盐酸盐(MPH)使用的循证推荐。指南建议MPH用于改善持续注意与加工速度,可用于改善选择性注意及抑郁症状,但不应用于改善执行功能或工作记忆。
要点
- MPH应推荐用于改善TBI成人持续注意与加工速度表现。
- MPH可推荐用于改善TBI成人选择性注意表现。
- MPH不推荐用于改善TBI成人执行功能或工作记忆表现。
核心结论
- MPH应推荐用于改善TBI成人持续注意与加工速度表现,可推荐用于改善选择性注意表现。
- MPH应推荐用于TBI成人抑郁症状的改善,尤其当快速缓解抑郁症状和/或治疗共病认知障碍为临床优先时。
- MPH不应推荐用于改善TBI成人执行功能或工作记忆表现。
研究设计与样本
- 指南由美国康复医学大会多学科作者小组制定,成员涵盖物理医学与康复、基础/转化科学、神经病学、行为神经病学与神经精神病学、护理及神经心理学。
- 推荐理由与推荐意见基于 accompanying 系统综述的证据,推荐生成与定稿遵循2017年美国神经病学学会指南制定与流程手册。
主要发现
- MPH在TBI成人中通常耐受良好。
- 临床医生应建立治疗联盟并应用TBI患者药物治疗原则,以识别MPH使用指征与禁忌证、促进治疗依从性并优化结局。
- 处方MPH时应遵循标准评估、教育、给药与监测建议,以优化安全性与耐受性。
关键数值与推荐
- MPH应推荐用于改善TBI成人持续注意与加工速度表现。
- MPH可推荐用于改善TBI成人选择性注意表现。
- MPH应推荐用于改善TBI成人抑郁症状,当快速缓解抑郁症状和/或治疗共病认知障碍为临床优先时。
- MPH不应推荐用于改善TBI成人执行功能或工作记忆表现。
临床怎么用
- 对TBI后存在持续注意或加工速度障碍的成人,可考虑推荐MPH。
- 对TBI后存在选择性注意障碍的成人,可考虑推荐MPH。
- 对TBI后抑郁症状需快速缓解或共病认知障碍需治疗为临床优先的成人,可考虑推荐MPH。
- 不应以改善执行功能或工作记忆为目的对TBI成人推荐MPH。
- 处方MPH时应遵循标准评估、教育、给药与监测建议,并建立治疗联盟以促进依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This clinical practice guideline (CPG) provides evidence-informed recommendations on the use of methylphenidate hydrochloride (MPH) in adults with cognitive and noncognitive neuropsychiatric symptoms in the subacute or chronic periods after traumatic brain injury (TBI). The CPG was developed by an American Congress of Rehabilitation Medicine multidisciplinary author panel with expertise in brain injury rehabilitation and included professionals in physical medicine and rehabilitation, basic/translational science, neurology, behavioral neurology and neuropsychiatry, nursing, and neuropsychology. Rationales and recommendations were written based on evidence from an accompanying systematic review. The generation and finalization of CPG recommendations followed procedures in the 2017 American Academy of Neurology Guideline Development and Process Manual. Clinicians should establish a therapeutic alliance and apply principles of pharmacotherapy in persons with TBI to identify indications for and contraindications to MPH use, facilitate treatment adherence, and optimize outcomes. MPH should be offered to improve sustained attention and processing speed performance and may be offered to improve selective attention performance among adults with TBI. MPH should be offered to improve depressive symptoms among adult patients with TBI in whom rapid resolution of depressive symptoms and/or treatment of co-occurring cognitive impairments are clinical priorities. MPH should not be offered to improve performance in executive functioning or working memory among adults with TBI. Although MPH is usually well tolerated among adults with TBI, clinicians should follow standard assessment, education, dosing, and monitoring recommendations when prescribing MPH to optimize its safety and tolerability. A summary of all recommendations on the use of MPH in TBI is available at the end of the CPG.
引用
- Arciniegas DB, Seel RT, Macciocchi SN, et al. Practice Guideline for Methylphenidate Use in Persons With Traumatic Brain Injury: Report of the American Congress of Rehabilitation Medicine. Arch Phys Med Rehabil. 2025. PMID: 41297654. doi:10.1016/j.apmr.2025.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。